Talphera (TLPH)

• Market cap: $41.3M
• 1 day: -0.58%
• 5 days: 0.58%
• 1 month: 5.98%
• 3 months: -29.11%
• 6 months: 4.25%
• Year to date: -23.61%
• 1 year: 67.19%
• 5 years: -97.7%
• 10 years: -98.76%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13